The next question is why would Novartis deal with Ronin vs dealing directly with Peregrine ? Hmmmm
Because Ronin has many years of experience dealing with the big pharma/boys and making money. The 3 current idiot board members are 3 crooks that gave themselves huge salaries, didn't buy many shares of the company that they are supposedly looking out for, didn't put an MD on the board of a biotech LOL, etc, etc
Eric Swartz 96,017 Shares 518,000 Dollars David Pohl 286 Shares 488,000 Dollars Carlton Johnson 1095 Shares 548,000 Dollars
Market Data 
Markets 
AI
